Suppr超能文献

尼古丁对大鼠肾血管舒张作用的细胞机制的药理学特征

Pharmacological characterization of cellular mechanisms of the renal vasodilatory effect of nicotine in rats.

作者信息

El-Mas Mahmoud M, El-Gowilly Sahar M, Gohar Eman Y, Ghazal Abdel-Rheem M

机构信息

Department of Pharmacology, Faculty of Pharmacy, University of Alexandria, Alexandria, Egypt.

出版信息

Eur J Pharmacol. 2008 Jul 7;588(2-3):294-300. doi: 10.1016/j.ejphar.2008.04.048. Epub 2008 Apr 30.

Abstract

Nicotine causes vasodilation in the renal vasculature through as yet unidentified mechanism. This study investigated the role of endothelial and non-endothelial factors in the vasodilatory action of nicotine in the rat isolated kidney. Nicotine vasodilation in phenylephrine-preconstricted perfused kidneys was evaluated in the absence and presence of drugs that interfere with nitric oxide synthase (NOS), K+ channels, cholinergic or adrenergic activity. Nicotine infusion (5 x 10(-5), 1 x 10(-4), and 5 x 10(-4) M) produced concentration-dependent decreases in the renal perfusion pressure, which continued for 20 min with a peak depressor effect observed at approximately 3 min. Nicotine vasodilation was associated with increases in norepinephrine and NO metabolites (nitrite/nitrate, NOx) levels in the renal effluent. Chemical denudation of the endothelium with 3-[(3-cholamidopropyl)-dimethyl-ammonio]-1-propane-sulfonate (CHAPS), or inhibition of NOS (NG-nitro-L-arginine, L-NNA), or guanylate cyclase (methylene blue) almost abolished the renal vasodilatory action of nicotine. Nicotine vasodilation was also significantly attenuated after selective blockade of ATP-sensitive (K(ATP), glibenclamide) or inward rectifier (Kir, BaCl2) K+ channels but remained unaltered after blockade of large-conductance calcium-activated (BKCa, tetraethylammonium, TEA) or voltage-dependent (Kv, 4-aminopyridine) K+ channels. Hexamethonium (ganglionic blocker), propranolol (beta-adrenceptor blocker), guanethidine (adrenergic neuron blocker), atropine (muscarinic antagonist) or the use of kidneys preconstricted with 80 mM KCl reduced the vasodepressor action of nicotine. Finally, exposure to diclophenac or neostigmine had no effect on nicotine vasodilation. Together, these findings implicate endothelial NOS and KATP and Kir channels in the renal vasodepressor effect of nicotine. Further, the sympathetic-dependent NO-mediated neurogenic vasodilation apparently contributes, at least partly, to nicotine vasodilation.

摘要

尼古丁通过尚未明确的机制导致肾血管舒张。本研究调查了内皮因子和非内皮因子在尼古丁对大鼠离体肾脏血管舒张作用中的作用。在存在和不存在干扰一氧化氮合酶(NOS)、钾通道、胆碱能或肾上腺素能活性的药物的情况下,评估尼古丁在去氧肾上腺素预收缩的灌注肾脏中的血管舒张作用。输注尼古丁(5×10⁻⁵、1×10⁻⁴和5×10⁻⁴ M)导致肾灌注压呈浓度依赖性下降,持续20分钟,在约3分钟时观察到最大降压效应。尼古丁血管舒张与肾流出液中去甲肾上腺素和NO代谢产物(亚硝酸盐/硝酸盐,NOx)水平升高有关。用3-[(3-胆酰胺丙基)-二甲基-铵]-1-丙烷磺酸盐(CHAPS)进行内皮化学剥脱,或抑制NOS(NG-硝基-L-精氨酸,L-NNA)或鸟苷酸环化酶(亚甲蓝)几乎消除了尼古丁的肾血管舒张作用。选择性阻断ATP敏感性(KATP,格列本脲)或内向整流(Kir,氯化钡)钾通道后,尼古丁血管舒张也显著减弱,但阻断大电导钙激活(BKCa,四乙铵,TEA)或电压依赖性(Kv,4-氨基吡啶)钾通道后,尼古丁血管舒张未改变。六甲铵(神经节阻滞剂)、普萘洛尔(β肾上腺素受体阻滞剂)、胍乙啶(肾上腺素能神经元阻滞剂)、阿托品(毒蕈碱拮抗剂)或使用80 mM氯化钾预收缩的肾脏可降低尼古丁的血管舒张降压作用。最后,暴露于双氯芬酸或新斯的明对尼古丁血管舒张无影响。总之,这些发现表明内皮NOS以及KATP和Kir通道参与了尼古丁的肾血管舒张降压作用。此外,交感神经依赖性NO介导的神经源性血管舒张显然至少部分地促成了尼古丁血管舒张。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验